Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Er, Chaozer"'
Autor:
Cohen, Alexander T., Creeper, Katherine J., Alikhan, Raza, Er, Chaozer, Connors, Jean M., Huisman, Menno V., Munoz, Andres, Vescovo, Giorgio, Bauersachs, Rupert, Ageno, Walter, Agnelli, Giancarlo, Becattini, Cecilia
Publikováno v:
Thrombosis & Haemostasis; Jul2024, Vol. 124 Issue 7, p676-683, 8p
Publikováno v:
Clinical Medicine. Mar2023, Vol. 23 Issue 2, p170-172. 3p.
Autor:
Er, Chaozer, Cohen, Alexander T.
Publikováno v:
In Research and Practice in Thrombosis and Haemostasis January 2023 7(1)
Publikováno v:
International Journal of Angiology (Thieme Medical Publishing Inc.); Jun2023, Vol. 32 Issue 2, p146-152, 7p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Navin Kuthiah, Er Chaozer
Publikováno v:
The Journal of the Royal College of Physicians of Edinburgh, Vol 49, Iss 3, Pp 217-221 (2019)
The incidence and prevalence of nontuberculous mycobacteria (NTM) infection is on the rise with many cases still going unreported. Given the vague and nonspecific clinical features of NTM infections, it is often missed or mistaken for Mycobacterium t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2978a8dee5c2f57591803380dfb76489
https://www.rcpe.ac.uk/college/journal/hypercalcaemia-secondary-disseminated-mycobacterium-abscessus-and-mycobacterium
https://www.rcpe.ac.uk/college/journal/hypercalcaemia-secondary-disseminated-mycobacterium-abscessus-and-mycobacterium
Autor:
Aravamudan, Veeraraghavan Meyyur1, Er, Chaozer1, Hussain, Ikram1, Cheong, Nicholas wong wai1, Chern Hao, Chong1, Kuthah, Navin1, En-Xian Tan, Emily1, Fan, Bingwen Eugene2
Publikováno v:
Case Reports in Medicine. 12/24/2018, p1-4. 4p.
Autor:
Nurul Atiqa Binte Mohd Tahir, Nicholas Wong Wai Cheong, Hejing Tan, Er Chaozer, Clarissa Hui Wen Aw, Joelynn Qiao Bin Tay
Publikováno v:
Clin Med (Lond)
Our hospital’s reference range for phosphate is 0.85–1.45 mmol/L. Oral replacement is generally adequate for mild and moderate hypophosphataemia >0.3 mmol/L).[1,2][1] Intravenous (IV) phosphate replacement carries many potential side effects and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bbd13b3421d094e7b2fab08b3de4f37
https://pubmed.ncbi.nlm.nih.gov/32409393
https://pubmed.ncbi.nlm.nih.gov/32409393
Publikováno v:
International Journal of Angiology (Thieme Medical Publishing Inc.); 2021, Vol. 30 Issue 4, p299-304, 6p